172 related articles for article (PubMed ID: 33400408)
1. Prescribing Isotretinoin for Transgender Patients: A Call to Action and Recommendations.
Sanchez DP; Brownstone N; Thibodeaux Q; Reddy V; Myers B; Chan S; Bhutani T
J Drugs Dermatol; 2021 Jan; 20(1):106-108. PubMed ID: 33400408
[TBL] [Abstract][Full Text] [Related]
2. Acne and the Lesbian, Gay, Bisexual, or Transgender Teenager.
Ragmanauskaite L; Kahn B; Ly B; Yeung H
Dermatol Clin; 2020 Apr; 38(2):219-226. PubMed ID: 32115131
[TBL] [Abstract][Full Text] [Related]
3. Challenges to Prescribing Isotretinoin to Patients at a Safety Net Hospital Dermatology Clinic.
Trupiano N; Brown C; Marji JS
J Drugs Dermatol; 2024 Jun; 23(6):477-479. PubMed ID: 38834207
[No Abstract] [Full Text] [Related]
4. We Pledge to Change iPLEDGE.
Pierson JC; Ferris LK; Schwarz EB
JAMA Dermatol; 2015 Jul; 151(7):701-2. PubMed ID: 25853235
[No Abstract] [Full Text] [Related]
5. A pox on your practice. iPLEDGE program scars dermatologists.
Ortolon K
Tex Med; 2006 May; 102(5):29-31. PubMed ID: 17115578
[No Abstract] [Full Text] [Related]
6. Transgender adolescents and acne: A cases series.
Campos-Muñoz L; López-De Lara D; Rodríguez-Rojo ML; Conde-Taboada A; López-Bran E
Pediatr Dermatol; 2018 May; 35(3):e155-e158. PubMed ID: 29575091
[TBL] [Abstract][Full Text] [Related]
7. Severe acne fulminans following low-dose isotretinoin and testosterone use.
Barańska-Rybak W; Mehrholz D; Flis P; Karpinsky G; Sokołowska-Wojdyło M
Cutis; 2019 Jun; 103(6):E20-E21. PubMed ID: 31348466
[No Abstract] [Full Text] [Related]
8. Optimizing Isotretinoin Treatment of Acne: Update on Current Recommendations for Monitoring, Dosing, Safety, Adverse Effects, Compliance, and Outcomes.
Landis MN
Am J Clin Dermatol; 2020 Jun; 21(3):411-419. PubMed ID: 32107726
[TBL] [Abstract][Full Text] [Related]
9. The need for restricted prescription of retinoic acid derivative isotretinoin to prevent retinoid teratogenicity.
De Santis M; Straface G; Cavaliere A; Nobili E; Caruso A
Prev Med; 2007; 45(2-3):243-4. PubMed ID: 17640721
[No Abstract] [Full Text] [Related]
10. Acne fulminans following isotretinoin therapy.
Didona D; Paolino G; Cantisani C; Viti G; Caposiena Caro DR; Didona B
G Ital Dermatol Venereol; 2019 Feb; 154(1):84-85. PubMed ID: 28712269
[No Abstract] [Full Text] [Related]
11. A Call for Gender Identity Data Collection in iPLEDGE and Increasing the Number of Isotretinoin Prescribers Among Transgender Health Providers.
Singer S; Keuroghlian AS
LGBT Health; 2020 Jul; 7(5):216-219. PubMed ID: 32456537
[TBL] [Abstract][Full Text] [Related]
12. Depression in transgender adolescents under treatment with isotretinoin.
Campos-Muñoz L; López-De Lara D; Conde-Taboada A; Fueyo Casado A; López-Bran E
Clin Exp Dermatol; 2020 Jul; 45(5):615-616. PubMed ID: 32064651
[No Abstract] [Full Text] [Related]
13. Treating Acne in Transgender Persons Receiving Testosterone: A Practical Guide.
Radi R; Gold S; Acosta JP; Barron J; Yeung H
Am J Clin Dermatol; 2022 Mar; 23(2):219-229. PubMed ID: 35018581
[TBL] [Abstract][Full Text] [Related]
14. [Systemic retinoid therapy in severe acne infantum].
Hütten M; Baron JM; Ott H
Hautarzt; 2008 Jun; 59(6):454-7. PubMed ID: 18470501
[No Abstract] [Full Text] [Related]
15. Advice on the safe introduction and continued use of isotretinoin in acne in the U.K. 2010.
Goodfield MJ; Cox NH; Bowser A; McMillan JC; Millard LG; Simpson NB; Ormerod AD
Br J Dermatol; 2010 Jun; 162(6):1172-9. PubMed ID: 21250961
[No Abstract] [Full Text] [Related]
16. Isotretinoin (roaccutane) usage--a South African consensus guideline. National Dermatology Working Group.
S Afr Med J; 1997 Oct; 87(10 Pt 2):1410-3. PubMed ID: 11496385
[TBL] [Abstract][Full Text] [Related]
17. [Isotretinoin. How should it be used?].
Thielitz A; Gollnick H
Hautarzt; 2013 Apr; 64(4):263-8. PubMed ID: 23515581
[TBL] [Abstract][Full Text] [Related]
18. Severe Acne in Female-to-Male Transgender Patients.
Turrion-Merino L; Urech-García-de-la-Vega M; Miguel-Gomez L; Harto-Castaño A; Jaen-Olasolo P
JAMA Dermatol; 2015 Nov; 151(11):1260-1. PubMed ID: 25992965
[No Abstract] [Full Text] [Related]
19. Is oral isotretinoin the treatment of choice in moderate and severe inflammatory acne vulgaris?
Verros CD; Rallis E
J Eur Acad Dermatol Venereol; 2007 Oct; 21(9):1270-1. PubMed ID: 17894728
[No Abstract] [Full Text] [Related]
20. On isotretinoin dosing, adverse effects, and efficacy.
Berk DR
Australas J Dermatol; 2011 May; 52(2):147-8; author reply 148. PubMed ID: 21605103
[No Abstract] [Full Text] [Related]
[Next] [New Search]
